Fundz

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer

PUBLIC · BCYCJun 23, 2023

Company

Bicycle Therapeutics

BiotechnologyHealth CareTherapeuticsPharmaceutical

Description

Bicycle Therapeutics plc , a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, today announced the appointment of Alethia Young as its new Chief Financial Officer, effective July 17th. Ms. Young joins Bicycle from Graphite Bio, where she served as Chief Financial Officer, and previously served as senior biotech analyst and head of research at Cantor Fitzgerald.","In addition, Bicycle announced the promotion of Travis Thompson, Senior Vice President, Finance, to Senior Vice President, Chief Accounting Officer

Quick answer

Bicycle Therapeutics Appoints Alethia Young as Chief Financial Officer (June 23, 2023).

What did Bicycle Therapeutics announce on June 23, 2023?
Bicycle Therapeutics plc , a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology, today announced the appointment of Alethia Young as its new Chief Financial Officer, effective July 17th.
What does Bicycle Therapeutics do?
Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of...
Which similar companies made leadership changes around the same time?
Virpax Pharmaceuticals (June 20, 2023), AbbVie Inc. (June 29, 2023), Damona Pharmaceuticals (June 13, 2023) and EyePoint, Inc. (July 10, 2023) also announced leadership changes within 45 days of Bicycle Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Bicycle Therapeutics, and when

A new leader at Bicycle Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Bicycle Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bicycle Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bicycle Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bicycle Therapeutics

About

Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company that is harnessing the power of bicyclic peptides and leveraging Nobel Prize-winning science to develop a new and differentiated class of medicines to treat cancer and other diseases. Bicycle® molecules are fully synthetic short peptides constrained with small molecule scaffolds to form two loops that stabilize their structural geometry. This constraint facilitates target binding with high affinity and selectivity, making Bicycle molecules attractive candidates for drug development.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bicycle Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Kevin
Likely contact at this company
••••••••@••••••••

See Kevin's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Bicycle Therapeutics's next move

Learn about Strategic plan

Bicycle Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.